Kuehne + Nagel forms strategic partnership with Chinese pharma specialist

Transport and logistics company, Kuehne + Nagel, has partnered with Jointown, China’s largest non-state-owned pharmaceutical distributor.

Kuehne + Nagel has been especially focused on developing pharma and healthcare expertise for the past decade. The partnership with Jointown now affords access to the company’s fully GxP-compliant, in-country storage and distribution network, enabling Kuehne + Nagel to comply with the highly-regulated Chinese pharma and healthcare sector.

“We are pleased to be partnering with Jointown,” said Kuehne + Nagel Asia Pacific President, Siewloong Wong.

“Our cooperation perfectly meets the demands of our global clientele by enabling seamless supply chain coverage connecting China. This will enable us to accelerate our growth in the pharma and healthcare sector in China.”

Jointown Pharmaceutical Group General Manager of the logistics business unit, Zhang Qingsong, said partnering with Kuehne + Nagel will provide Jointown’s customers access to the international market via global GxP certified air, sea and overseas contract logistics operations.

“We will now be able to expand our business in overseas markets at a much faster pace and benefit from the partnership in a sustainable way,” said Qingsong.

With Covid-19 vaccines becoming widely approved for use in more countries, Jointown and Kuehne + Nagel will collaborate to manage vaccine distribution in a safe and timely manner, leveraging their respective strengths in vaccine storage and distribution both in China and other parts of the world.

“Pharma & Healthcare is one of the fastest growing sectors in Contract Logistics,” said Gianfranco Sgro, Member of the Management Board of Kuehne + Nagel International AG, responsible for Contract Logistics. “Kuehne + Nagel and Jointown share a common vision of service excellence for patients and customers in China and abroad.”

In recent news, Kuehne + Nagel agreed to acquire Apex International Corporation.

In January, Kuehne + Nagel entered an international supply chain agreement to store and distribute Moderna’s Covid-19 vaccine.